Department of Animal Science, University of California, Davis, California 95616, USA; email:
Department of Agricultural Sciences, Clemson University, Clemson, South Carolina 29632, USA; email:
Annu Rev Anim Biosci. 2021 Feb 16;9:453-478. doi: 10.1146/annurev-animal-061220-023052. Epub 2020 Nov 13.
Genetically engineered (GE) livestock were first reported in 1985, and yet only a single GE food animal, the fast-growing AquAdvantage salmon, has been commercialized. There are myriad interconnected reasons for the slow progress in this once-promising field, including technical issues, the structure of livestock industries, lack of public research funding and investment, regulatory obstacles, and concern about public opinion. This review focuses on GE livestock that have been produced and documents the difficulties that researchers and developers have encountered en route. Additionally, the costs associated with delayed commercialization of GE livestock were modeled using three case studies: GE mastitis-resistant dairy cattle, genome-edited porcine reproductive and respiratory syndrome virus-resistant pigs, and the AquAdvantage salmon. Delays of 5 or 10 years in the commercialization of GE livestock beyond the normative 10-year GE product evaluation period were associated with billions of dollars in opportunity costs and reduced global food security.
基因工程(GE)牲畜于 1985 年首次报道,但迄今为止,只有一种基因工程食品动物——快速生长的 AquAdvantage 三文鱼——实现了商业化。在这个曾经充满希望的领域,进展缓慢有无数相互关联的原因,包括技术问题、牲畜产业结构、缺乏公共研究资金和投资、监管障碍以及对公众意见的担忧。本综述重点介绍了已经生产的基因工程牲畜,并记录了研究人员和开发者在这一过程中遇到的困难。此外,还使用三个案例研究对基因工程牲畜延迟商业化的相关成本进行了建模:基因工程抗乳腺炎奶牛、基因组编辑的猪繁殖与呼吸综合征病毒抗性猪和 AquAdvantage 三文鱼。与规范的 10 年基因工程产品评估期相比,基因工程牲畜的商业化延迟 5 年或 10 年,将导致数十亿美元的机会成本损失和全球粮食安全水平降低。